Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04044820
Other study ID # 18-5539
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date March 4, 2019
Est. completion date December 31, 2023

Study information

Verified date October 2022
Source University Health Network, Toronto
Contact Anuj Bhatia, MD FRCPC
Phone (416) 603 5800
Email anuj.bhatia@uhn.ca
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The aim of this study is to determine if a standardized evidence-based opioid prescription following elective hand and forearm surgery at Toronto Western Hospital (TWH) will decrease the number of unused opioid pills consumed by patients while still maintaining adequate pain control as compared to usual treatment. Currently, no standardized prescription exists at our institution.


Description:

This study is a Prospective Randomized Controlled Trial with an aim to determine if a standardized discharge prescription provides effective analgesia while reducing the number of unused opioid pills in the community. All patients presenting to TWH during the recruitment phase for elective ambulatory hand and arm surgery will be asked to participate in the study. Patients will be given information about the study in the pre-operative surgical clinic by the surgeon assessing them. If agreeable, patients will then be approached for recruitment by a research assistant. Patients would be randomized to either standardized prescription arm versus control arm (usual prescriptions administered by physician). The standardized prescription will consist of an opioid prescription for Oxycodone 5mg PO q4-6h PRN. Alternatively, if the patient has an allergy or other contraindication to Oxycodone, Hydromorphone 1mg PO q4-6h PRN or Tylenol #3 1-2 tablets PO q4h PRN will be given. The number of tablets prescribed will depend on the extent of surgical trauma, as per a previously conducted study. As part of the standardized prescription group, patients will receive a handout (encouraging them to use non-opioid analgesics along with the opioid prescription to minimize their narcotic consumption). Participants will be asked a series of questions via telephone consultation or in the pre-operative waiting area about their current opioid use, as well as their risk for narcotic abuse using the opioid risk tool (ORT). Participants will also be asked to fill out questionnaires assessing components of neuropathic pain (DN-4), any elements of anxiety or depression (HADS), and any tendencies for catastrophizing (PCS). At the time of discharge participants will then be provided with either the standardized prescription or the usual discharge prescription by the surgeon. Patients will be called after discharge from hospital on post-discharge weeks 1, 6, and 12 by either clinical investigators or research assistants. Patients will be asked standardized questions about their pain with the goal of assessing our primary endpoint of number of opioid pills used as compared to number prescribed. Patients will be attempted to be reached by telephone up to 3 times during the 7 day period following each pre-defined time point (i.e. 1, 6 and 12 weeks). Subsequently the proportion of unused opioid pills will be calculated for each group.


Recruitment information / eligibility

Status Recruiting
Enrollment 292
Est. completion date December 31, 2023
Est. primary completion date September 2023
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: 1. Patients presenting to TWH for elective ambulatory hand and forearm surgery Exclusion Criteria: 1. Chronic opioid treatment, defined as more than 6 tablets of Oxycodone 5 mg per day (or equivalent) 2. Cognitive impairment or any other condition causing inability to use 'as required' medication for pain control 3. Language barrier preventing completion of patient diary 4. Patient refusal

Study Design


Related Conditions & MeSH terms


Intervention

Drug:
Standardized Prescription
Oxycodone 5mg PO q4-6h PRN If patient has allergy or other contraindications Hydromorphone 1mg PO q4-6h PRN/ Tylenol #3 1-2 tablets PO q4h PRN The number of tablets prescribed will depend on the extent of surgical trauma 0-5 pills for simple surgeries such as a trigger finger release 10 pills for carpal tunnel or Dupuytren's contracture releases 15 pills for a ganglion cyst excision or simple tendon transfer 20 pills for more complex procedures such as distal forearm ORIF or a wrist fusion.

Locations

Country Name City State
Canada Toronto Western Hospital Toronto Ontario

Sponsors (1)

Lead Sponsor Collaborator
University Health Network, Toronto

Country where clinical trial is conducted

Canada, 

Outcome

Type Measure Description Time frame Safety issue
Other Correlation of patient anxiety on pain numerical rating scores (0-10) Twelve weeks after intervention compared to pre-intervention
Other Correlation of patient anxiety on opioid consumption Twelve weeks after intervention compared to pre-intervention
Other Correlation of patient depression on pain numerical rating scores (0-10) Twelve weeks after intervention compared to pre-intervention
Other Correlation of patient depression on opioid consumption Twelve weeks after intervention compared to pre-intervention
Other Correlation of patient catastrophizing on pain numerical rating scores (0-10) Twelve weeks after intervention compared to pre-intervention
Other Correlation of patient catastrophizing on opioid consumption Twelve weeks after intervention compared to pre-intervention
Other Correlation of patient's score on the opioid risk tool (ORT) on post-op opioid use Twelve weeks after intervention compared to pre-intervention
Primary Impact of Standardized prescription on quality of analgesia after hand and forearm surgery Twelve weeks after intervention
Secondary Incidence of adverse effects of opioid medications experienced by patients One week, Six weeks and Twelve weeks after intervention
Secondary Correlation of opioid consumption to pain scores One week, Six weeks and Twelve weeks after intervention
Secondary Correlation of opioid consumption to functional limitations post-operatively as measured by the Disabilities of Arm Shoulder and Hand (DASH) score Six weeks and Twelve weeks after intervention compared to pre-intervention
Secondary Incidence of disposal practices of prescribed opioids by patients To indicate the type and incidence of disposal practices of prescribed opioids for patients (returned to pharmacy, retaining pills at home, and self-disposal of medication by participants One week, Six weeks and Twelve weeks after intervention
Secondary Patient satisfaction with pain management after discharge (as measured on a 0 to 10 scale, 0 being completely dissatisfied, and 10 being completely satisfied) One week, Six weeks and Twelve weeks after intervention
Secondary The mean number of days patients require post-discharge opioid medications One week, Six weeks and Twelve weeks after intervention
Secondary The correlation between in-hospital opioid analgesic requirements and post-discharge opioid consumption (all converted to oral morphine equivalents) One week, Six weeks and Twelve weeks after intervention
Secondary The proportion of patients that require additional opioid prescription(s), on top of what is given at discharge, during the follow-up period, and 12 weeks One week, Six weeks and Twelve weeks after intervention
Secondary The incidence of neuropathic pain as diagnosed by DN4 score >3/10 Twelve weeks after intervention compared to pre-intervention
Secondary Impact of Standardized prescription on quality of analgesia after hand and forearm surgery One week after intervention
Secondary Impact of Standardized prescription on number of unused opioid medications after hand and forearm surgery One week after intervention
Secondary Impact of Standardized prescription on quality of analgesia after hand and forearm surgery Six weeks after intervention
Secondary Impact of Standardized prescription on number of unused opioid medications after hand and forearm surgery Six weeks after intervention
See also
  Status Clinical Trial Phase
Recruiting NCT04095624 - Does Preoperative Pain Medication Management Influence Surgical Outcomes in Spinal Fusion N/A
Completed NCT04484610 - Appropriate Opioid Quantities for Acute Pain - Pharmacist Study Phase 4
Recruiting NCT04598074 - Opioid Package Prototype (OPP) N/A
Recruiting NCT06033599 - Motivational Interviewing and Mindfulness-Oriented Recovery Enhancement Phase 3
Recruiting NCT06032559 - Implementation and Effectiveness of Mindfulness Oriented Recovery Enhancement as an Adjunct to Methadone Treatment Phase 3
Completed NCT05845177 - Persistent Pain After Hip Replacement
Completed NCT03268551 - MEMO-Medical Marijuana and Opioids Study
Completed NCT03570320 - Does Altering Narcotic Prescription Methods Affect Opioid Distribution Following Select Upper Extremity Surgeries? N/A
Completed NCT04526236 - Influence of Aging on Perioperative Methadone Dosing Phase 4
Completed NCT05593341 - Opioid Education in Total Knee Arthroplasty N/A
Recruiting NCT06055205 - A Pain and Coordination Plan for Reduced Opioid Use After Accidental Injuries N/A
Recruiting NCT05877157 - Pain AND Opioids After Surgery
Recruiting NCT03675386 - Reducing Opioid Use for Chronic Pain Patients Following Surgery N/A
Suspended NCT05001789 - Cognitive Functioning in Opioid Use Disorder N/A
Completed NCT04296396 - Opioid Prescription After Cesarean Trial Phase 3
Not yet recruiting NCT04868552 - Naloxone Education in Total Joint Patients N/A
Completed NCT03540030 - Opioid-Free Shoulder Arthroplasty Phase 4
Terminated NCT06217380 - Feasibility and Acceptability of Oxygen Saturation Monitoring Using Masimo SafetyNet Alert (MSNA) in a Supportive Housing Program N/A
Recruiting NCT05976646 - Phase Ib/2a Drug-drug Interaction Study of a Combination of 45mg Dextromethorphan With 105 mg Bupropion Phase 1/Phase 2
Completed NCT03472521 - Prevention of Persistent Opioid Use in Mothers Phase 4